Annual CFI
$11.54 M
+$55.94 M+126.00%
December 31, 2023
Summary
- As of February 8, 2025, ELEV annual cash flow from investing activities is $11.54 million, with the most recent change of +$55.94 million (+126.00%) on December 31, 2023.
- During the last 3 years, ELEV annual CFI has risen by +$11.61 million (+16357.75%).
- ELEV annual CFI is now at all-time high.
Performance
ELEV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$2.87 M
+$34.79 M+92.37%
September 30, 2024
Summary
- As of February 8, 2025, ELEV quarterly cash flow from investing activities is -$2.87 million, with the most recent change of +$34.79 million (+92.37%) on September 30, 2024.
- Over the past year, ELEV quarterly CFI has stayed the same.
- ELEV quarterly CFI is now -110.80% below its all-time high of $26.60 million, reached on March 31, 2023.
Performance
ELEV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$13.27 M
+$35.24 M+72.64%
September 30, 2024
Summary
- As of February 8, 2025, ELEV TTM cash flow from investing activities is -$13.27 million, with the most recent change of +$35.24 million (+72.64%) on September 30, 2024.
- Over the past year, ELEV TTM CFI has stayed the same.
- ELEV TTM CFI is now -119.62% below its all-time high of $67.65 million, reached on June 30, 2023.
Performance
ELEV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ELEV Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.0% | 0.0% | 0.0% |
| 3 y3 years | +10000.0% | -125.7% | +70.1% |
| 5 y5 years | - | -125.7% | +70.1% |
ELEV Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +126.0% | -110.8% | +96.4% | -119.6% | +83.3% |
| 5 y | 5-year | at high | +126.0% | -110.8% | +96.4% | -119.6% | +83.3% |
| alltime | all time | at high | +126.0% | -110.8% | +96.4% | -119.6% | +83.3% |
Elevation Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.87 M(-92.4%) | -$13.27 M(-72.6%) |
| Jun 2024 | - | -$37.66 M(-281.9%) | -$48.52 M(-959.8%) |
| Mar 2024 | - | $20.70 M(+215.5%) | $5.64 M(-51.1%) |
| Dec 2023 | $11.54 M(-126.0%) | $6.56 M(-117.2%) | $11.54 M(-28.6%) |
| Sep 2023 | - | -$38.12 M(-331.0%) | $16.16 M(-76.1%) |
| Jun 2023 | - | $16.50 M(-38.0%) | $67.65 M(+10.0%) |
| Mar 2023 | - | $26.60 M(+137.9%) | $61.47 M(-238.5%) |
| Dec 2022 | -$44.40 M | $11.18 M(-16.3%) | -$44.40 M(-20.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $13.37 M(+29.4%) | -$55.58 M(-19.4%) |
| Jun 2022 | - | $10.33 M(-113.0%) | -$68.94 M(-13.0%) |
| Mar 2022 | - | -$79.27 M(<-9900.0%) | -$79.27 M(<-9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | -$71.00 K | - | - |
FAQ
- What is Elevation Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Elevation Oncology?
- What is Elevation Oncology annual CFI year-on-year change?
- What is Elevation Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Elevation Oncology?
- What is Elevation Oncology quarterly CFI year-on-year change?
- What is Elevation Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Elevation Oncology?
- What is Elevation Oncology TTM CFI year-on-year change?
What is Elevation Oncology annual cash flow from investing activities?
The current annual CFI of ELEV is $11.54 M
What is the all time high annual CFI for Elevation Oncology?
Elevation Oncology all-time high annual cash flow from investing activities is $11.54 M
What is Elevation Oncology annual CFI year-on-year change?
Over the past year, ELEV annual cash flow from investing activities has changed by +$55.94 M (+126.00%)
What is Elevation Oncology quarterly cash flow from investing activities?
The current quarterly CFI of ELEV is -$2.87 M
What is the all time high quarterly CFI for Elevation Oncology?
Elevation Oncology all-time high quarterly cash flow from investing activities is $26.60 M
What is Elevation Oncology quarterly CFI year-on-year change?
Over the past year, ELEV quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Elevation Oncology TTM cash flow from investing activities?
The current TTM CFI of ELEV is -$13.27 M
What is the all time high TTM CFI for Elevation Oncology?
Elevation Oncology all-time high TTM cash flow from investing activities is $67.65 M
What is Elevation Oncology TTM CFI year-on-year change?
Over the past year, ELEV TTM cash flow from investing activities has changed by $0.00 (0.00%)